Skip to main content
SpringerLink
Log in
Book cover

Glioblastoma pp 299–323Cite as

Current Endeavors for Enhancing Efficacy of Paclitaxel for Treatment of Glioblastoma

  • Chapter
  • First Online:

Abstract

Paclitaxel, the plant-derived anticancer drug, has shown clinical efficacy against a wide variety of solid tumors such as breast cancer, ovarian cancer, nonsmall-cell lung cancer, and melanoma. The antineoplastic effect of paclitaxel is attributed to cell cycle arrest at G2/M phase and microtubule stabilization leading to activation of apoptosis. The use of paclitaxel in glioblastoma, which is a devastating brain tumor, is still limited and thus this is an emerging area to explore the strategies for using paclitaxel for the treatment of glioblastoma. A limited number of studies showed that paclitaxel possessed the potential to treat glioblastoma, but there were few concerns that limited its use in brain tumor. This chapter will focus on the current research that indicates how to overcome the difficulties and promising prospect of using paclitaxel in glioblastoma in the future.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Allen JN, Moore SA, Wewers MD (1993) Taxol enhances but does not induce interleukin-1β and tumor necrosis factor-alpha production. J Lab Clin Med 122:374–381

    CAS  PubMed  Google Scholar 

  • Altznauer F, Conus S, Cavalli A, Folkers G, Simon HU (2004) Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem 279:5947–5957

    Article  CAS  PubMed  Google Scholar 

  • Amos B, Lotan R (1990) Retinoid-sensitive cells and cell lines. Methods Enzymol 190:217–225

    Article  CAS  PubMed  Google Scholar 

  • Anderson CD, Wang J, Kumar GN, McMillan JM, Walle UK, Walle T (1995) Dexamethasone induction of taxol metabolism in the rat. Drug Metab Dispos 23:1286–1290

    CAS  PubMed  Google Scholar 

  • Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R (2001) Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 20:147–155

    Article  CAS  PubMed  Google Scholar 

  • Banks WA (1999) Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders. J Neurovirol 5:538–555

    Article  CAS  PubMed  Google Scholar 

  • Bhadra D, Bhadra S, Jain S, Jain NK (2003) A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int J Pharm 257:111–124

    Article  CAS  PubMed  Google Scholar 

  • Biswas KK, Tancharoen S, Sarker KP, Kawahara K, Hashiguchi T, Maruyama I (2006) Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt. FEBS Lett 580:703–710

    Article  CAS  PubMed  Google Scholar 

  • Blagosklonny MV, Fojo T (1999) Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer 83:151–156

    Article  CAS  PubMed  Google Scholar 

  • Bogdan C, Ding A (1992) Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. J Leukoc Biol 52:119–121

    CAS  PubMed  Google Scholar 

  • Burton E, Prados M (1999) New chemotherapy options for the treatment of malignant gliomas. Curr Opin Oncol 11:157–161

    Article  CAS  PubMed  Google Scholar 

  • Cahan MA, Walter KA, Colvin OM, Brem H (1994) Cytotoxicity of taxol in vitro against human and rat malignant brain tumors. Cancer Chemother Pharmacol 33:441–444

    Article  CAS  PubMed  Google Scholar 

  • Chamberlain MC, Kormanik P (1999) Salvage chemotherapy with taxol for recurrent anaplastic astrocytomas. J Neurooncol 43:71–78

    Article  CAS  PubMed  Google Scholar 

  • Choi YH (2006) Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity. Int J Oncol 29:1207–1213

    CAS  PubMed  Google Scholar 

  • Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, Dawson TM, Dawson VL, Park DS, Kroemer G, Slack RS (2002) Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 158:507–517

    Article  CAS  PubMed  Google Scholar 

  • Das A, Banik NL, Ray SK (2007) Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis. Neurochem Res 32:2167–2183

    Article  CAS  PubMed  Google Scholar 

  • Das A, Banik NL, Ray SK (2008) Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. J Neurooncol 87:9–22

    Article  CAS  PubMed  Google Scholar 

  • Deeken JF, Löscher W (2007) The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clin Cancer Res 13:1663–1674

    Article  CAS  PubMed  Google Scholar 

  • DePinho RA (2000) The age of cancer. Nature 408:248–254

    Article  CAS  PubMed  Google Scholar 

  • Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B, Martinou JC (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144:891–901

    Article  CAS  PubMed  Google Scholar 

  • Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B, Dykes D, Noker P, Yao R, Labao E, Hawkins M, Soon-Shiong P (2006) Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res 12:1317–1324; erratum in Clin Cancer Res 12:3869

    Google Scholar 

  • Ding AH, Porteu F, Sanchez E, Nathan CF (1990) Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 48:370–372

    Article  Google Scholar 

  • Dragnev KH, Rigas JR, Dmitrovsky E (2000) The retinoids and cancer prevention mechanisms. Oncologist 5:361–368

    Article  CAS  PubMed  Google Scholar 

  • Du C, Fang M, Li Y, Li L, Wang X (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33–42

    Article  CAS  PubMed  Google Scholar 

  • Eiseman JL, Eddington ND, Leslie J, MacAuley C, Sentz DL, Zuhowski M, Kujawa JM, Young D, Egorin MJ (1994) Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice. Cancer Chemother Pharmacol 34:465–471

    Article  CAS  PubMed  Google Scholar 

  • Eitel K, Wagenknecht B, Weller M (1999) Inhibition of drug-induced DNA fragmentation, but not cell death, of glioma cells by non-caspase protease inhibitors. Cancer Lett 142:11–16

    Article  CAS  PubMed  Google Scholar 

  • Ettinger DS (1993) Taxol in the treatment of lung cancer. J Natl Cancer Inst Monogr 15:177–179

    PubMed  Google Scholar 

  • Fan W (1999) Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol 57:1215–1221

    Article  CAS  PubMed  Google Scholar 

  • Fellner S, Bauer B, Miller DS, Schaffrik M, Fankhänel M, Spruss T, Bernhardt G, Graeff C, Färber L, Gschaidmeier H, Buschauer A, Fricker G (2002) Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Invest 110:1309–1318

    CAS  PubMed  Google Scholar 

  • Fleming AB, Saltzman WM (2002) Pharmacokinetics of the carmustine implant. Clin Pharmacokinet 41:403–419

    Article  CAS  PubMed  Google Scholar 

  • Fortin D, Desjardins A, Benko A, Niyonsega T, Boudrias M (2005) Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience. Cancer 103:2606–2615

    Article  PubMed  Google Scholar 

  • Gelderblom H, Verweij J, Nooter K, Sparreboom A (2001) Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 37:1590–1598

    Article  CAS  PubMed  Google Scholar 

  • Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O’Shaughnessy J (2005) Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 23(31):7794–7803

    Article  CAS  PubMed  Google Scholar 

  • Guo JM, Xiao BX, Kang GZ, Liu DH, Chen H, Zhang S, Zhang XN (2006) Suppression of telomerase activity and arrest at G1 phase in human cervical cancer HeLa cells by all-trans retinoic acid. Int J Gynecol Cancer 16:341–346

    Article  CAS  PubMed  Google Scholar 

  • Gupta S (2002) Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules. Exp Gerontol 37:293–299

    Article  CAS  PubMed  Google Scholar 

  • Haldar S, Jena N, Croce CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507–4511

    Article  CAS  PubMed  Google Scholar 

  • Haque A, Das A, Hajiaghamohseni LM, Younger A, Banik NL, Ray SK (2007) Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells. Cancer Immunol Immunother 56:615–625

    Article  CAS  PubMed  Google Scholar 

  • Heimans JJ, Vermorken JB, Wolbers JG, Eeltink CM, Meijer OW, Taphoorn MJ, Beijnen JH (1994) Paclitaxel (Taxol) concentrations in brain tumor tissue. Ann Oncol 5:951–953

    CAS  PubMed  Google Scholar 

  • Helson L, Helson C, Malik S, Ainsworth S, Mangiardi J (1993) A saturation threshold for taxol cytotoxicity in human glial and neuroblastoma cells. Anticancer Drugs 4:487–490

    Article  CAS  PubMed  Google Scholar 

  • Ho SY, Barbarese E, D’Arrigo JS, Smith-Slatas C, Simon RH (1997) Evaluation of lipid-coated microbubbles as a delivery vehicle for Taxol in brain tumor therapy. Neurosurgery 40:1260–1266

    Article  CAS  PubMed  Google Scholar 

  • Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN (1991) Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83:1797–1805

    CAS  PubMed  Google Scholar 

  • Hormi-Carver K, Feagins LA, Spechler SJ, Souza RF (2007) All trans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett’s cells. Am J Physiol Gastrointest Liver Physiol 292:G18–G27

    Article  CAS  PubMed  Google Scholar 

  • Huizing MT, Misser VH, Pieters RC, ten Bokkel Huinink WW, Veenhof CH, Vermorken JB, Pinedo HM, Beijnen JH (1995) Taxanes: a new class of antitumor agents. Cancer Invest 13:381–404

    Article  CAS  PubMed  Google Scholar 

  • Ji ZN, Ye WC, Liu GG, Hsiao WL (2002) 23-Hydroxybetulinic acid-mediated apoptosis is accompanied by decreases in bcl-2 expression and telomerase activity in HL-60 Cells. Life Sci 72:1–9

    Article  CAS  PubMed  Google Scholar 

  • Joo KM, Park K, Kong DS, Song SY, Kim MH, Lee GS, Kim MS, Nam DH (2008) Oral paclitaxel chemotherapy for brain tumors: ideal combination treatment of paclitaxel and P-glycoprotein inhibitor. Oncol Rep 19:17–23

    CAS  PubMed  Google Scholar 

  • Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–265

    Article  CAS  PubMed  Google Scholar 

  • Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162

    Article  CAS  PubMed  Google Scholar 

  • Karmakar S, Weinberg MS, Banik NL, Patel SJ, Ray SK (2006) Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane. Neuroscience 141:1265–1280

    Article  CAS  PubMed  Google Scholar 

  • Karmakar S, Banik NL, Patel SJ, Ray SK (2007) Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice. Apoptosis 12:2077–2087

    Article  CAS  PubMed  Google Scholar 

  • Karmakar S, Banik NL, Ray SK (2008) Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer 112:596–607

    Article  CAS  PubMed  Google Scholar 

  • Kemper EM, van Zandbergen AE, Cleypool C, Mos HA, Boogerd W, Beijnen JH, van Tellingen O (2003) Increased penetration of paclitaxel into the brain by inhibition of P-glycoprotein. Clin Cancer Res 9:2849–2855

    CAS  PubMed  Google Scholar 

  • Kemper EM, Boogerd W, Thuis I, Beijnen JH, van Tellingen O (2004) Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours? Cancer Treat Rev 30:415–423

    Article  PubMed  Google Scholar 

  • Kim R (2005) Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103:1551–1560

    Article  CAS  PubMed  Google Scholar 

  • Koga H, Inamura T, Ikezaki K, Nomura T, Samoto K, Fukui M (1996) Increased delivery of a new cisplatin analogue (254-S) in a rat brain tumor by an intracarotid infusion of bradykinin. Neurol Res 18:244–247

    CAS  PubMed  Google Scholar 

  • Korhonen L, Hansson I, Kukkonen JP, Brännvall K, Kobayashi M, Takamatsu K, Lindholm D (2005) Hippocalcin protects against caspase-12-induced and age-dependent neuronal degeneration. Mol Cell Neurosci 28:85–95

    Article  CAS  PubMed  Google Scholar 

  • Koziara JM, Lockman PR, Allen DD, Mumper RJ (2004) Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 99:259–269

    Article  CAS  PubMed  Google Scholar 

  • Koziara JM, Whisman TR, Tseng MT, Mumper RJ (2006) In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. J Control Release 112:312–319

    Article  CAS  PubMed  Google Scholar 

  • Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513–519

    Article  CAS  PubMed  Google Scholar 

  • Lee LF, Li G, Templeton DJ, Ting JP (1998) Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). J Biol Chem 273:28253–28260

    Article  CAS  PubMed  Google Scholar 

  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489

    Article  CAS  PubMed  Google Scholar 

  • Li KW, Dang W, Tyler BM, Troiano G, Tihan T, Brem H, Walter KA (2003) Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies. Clin Cancer Res 9:3441–3447

    CAS  PubMed  Google Scholar 

  • Linskey ME, Gilbert MR (1995) Glial differentiation: a review with implications for new directions in neuro-oncology. Neurosurgery 36:1–21; discussion 21–22

    Google Scholar 

  • Lopez S, Peiretti F, Bonardo B, Juhan-Vague I, Nalbone G (2000) Tumor necrosis factor alpha up-regulates in an autocrine manner the synthesis of plasminogen activator inhibitor type-1 during induction of monocytic differentiation of human HL-60 leukemia cells. J Biol Chem 275:3081–3087

    Article  CAS  PubMed  Google Scholar 

  • MacKeigan JP, Taxman DJ, Hunter D, Earp HS III, Graves LM, Ting JP (2002) Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition. Clin Cancer Res 8:2091–2099

    Google Scholar 

  • Manfredi JJ, Parness J, Horwitz SB (1982) Taxol binds to cellular microtubules. J Cell Biol 94:688–696

    Article  CAS  PubMed  Google Scholar 

  • Mangelsdorf DJ, Umesono K, Evans RM (1994) The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS (eds) The retinoids: biology chemistry and medicine, 2nd edn. Raven Press, New York, pp 319–349

    Google Scholar 

  • Manthey CL, Qureshi N, Stütz PL, Vogel SN (1993) Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages. J Exp Med 178:695–702

    Article  CAS  PubMed  Google Scholar 

  • Marupudi NI, Han JE, Li KW, Renard VM, Tyler BM, Brem H (2007) Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6:609–621

    Article  CAS  PubMed  Google Scholar 

  • Massard C, Zermati Y, Pauleau AL, Larochette N, Métivier D, Sabatier L, Kroemer G, Soria JC (2006) hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway. Oncogene 25:4505–4514

    Article  CAS  PubMed  Google Scholar 

  • McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC (1989) Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111:273–279

    CAS  PubMed  Google Scholar 

  • Merino R, Hurlé JM (2003) The molecular basis of retinoid action in tumors. Trends Mol Med 9:509–511

    Article  CAS  PubMed  Google Scholar 

  • Michaelis K, Hoffmann MM, Dreis S, Herbert E, Alyautdin RN, Michaelis M, Kreuter J, Langer K (2006) Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 317:1246–1253

    Article  CAS  PubMed  Google Scholar 

  • Mohamed AA, Jupp OJ, Anderson HM, Littlejohn AF, Vandenabeele P, MacEwan DJ (2002) Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not. Biochem J 366(part 1):145–155

    Google Scholar 

  • Mollinedo F, Gajate C (2003) Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8:413–450

    Article  CAS  PubMed  Google Scholar 

  • Nehmé A, Varadarajan P, Sellakumar G, Gerhold M, Niedner H, Zhang Q, Lin X, Christen RD (2001) Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells. Br J Cancer 84:1571–1576

    Article  PubMed  Google Scholar 

  • Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14:381–395

    Article  CAS  PubMed  Google Scholar 

  • Nimmanapalli R, Perkins CL, Orlando M, O’Bryan E, Nguyen D, Bhalla KN (2001) Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res 61:759–763

    CAS  PubMed  Google Scholar 

  • Oh-hashi K, Kaneyama M, Hirata Y, Kiuchi K (2006) ER calcium discharge stimulates GDNF gene expression through MAPK-dependent and -independent pathways in rat C6 glioblastoma cells. Neurosci Lett 405:100–105

    Article  CAS  PubMed  Google Scholar 

  • Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–619

    Article  CAS  PubMed  Google Scholar 

  • Panyam J, Labhasetwar V (2004) Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol Pharm 1:77–84

    Article  CAS  PubMed  Google Scholar 

  • Pardridge WM (1997) Drug delivery to the brain. J Cereb Blood Flow Metab 17:713–731

    Article  CAS  PubMed  Google Scholar 

  • Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2:3–14

    Article  PubMed  Google Scholar 

  • Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, Safa AR (2004) Taxol induces caspase-10-dependent apoptosis. J Biol Chem 279:51057–51067

    Article  CAS  PubMed  Google Scholar 

  • Parney IF, Chang SM (2005) Current chemotherapy for glioblastoma. In: Markert J, DeVita VT Jr, Rosenberg SA, Hellman S (eds) Glioblastoma multiforme, 1st edn. Jones and Bartlett, Sudbury, MA, pp 161–177

    Google Scholar 

  • Polster BM, Basañez G, Etxebarria A, Hardwick JM, Nicholls DG (2005) Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem 280:6447–6454

    Article  CAS  PubMed  Google Scholar 

  • Pradilla G, Wang PP, Gabikian P, Li K, Magee CA, Walter KA, Brem H (2006) Local intracerebral administration of Paclitaxel with the paclimer delivery system: toxicity study in a canine model. J Neurooncol 76:131–138

    Article  CAS  PubMed  Google Scholar 

  • Prados MD, Schold SC, Spence AM, Berger MS, McAllister LD, Mehta MP, Gilbert MR, Fulton D, Kuhn J, Lamborn K, Rector DJ, Chang SM (1996) Phase II study of paclitaxel in patients with recurrent malignant glioma. J Clin Oncol 14:2316–2321

    CAS  PubMed  Google Scholar 

  • Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, Bredesen DE, Ellerby HM (2002) Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem 277:21836–21842

    Article  CAS  PubMed  Google Scholar 

  • Raymond JJ, Robertson DM, Dinsdale HB (1986) Pharmacological modification of bradykinin induced breakdown of the blood-brain barrier. Can J Neurol Sci 13:214–220

    CAS  PubMed  Google Scholar 

  • Rice A, Liu Y, Michaelis ML, Himes RH, Georg GI, Audus KL (2005) Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situ. J Med Chem 48:832–838

    Article  CAS  PubMed  Google Scholar 

  • Riondel J, Jacrot M, Fessi H, Puisieux F, Potier P (1992) Effects of free and liposome-encapsulated taxol on two brain tumors xenografted into nude mice. In Vivo 6:23–27

    Google Scholar 

  • Roth W, Wagenknecht B, Grimmel C, Dichgans J, Weller M (1998) Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. Br J Cancer 77:404–411

    Article  CAS  PubMed  Google Scholar 

  • Rowinsky EK, Donehower RC, Jones RJ, Tucker RW (1988) Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res 48:4093–4100

    CAS  PubMed  Google Scholar 

  • Sakahira H, Enari M, Nagata S (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96–99

    Article  CAS  PubMed  Google Scholar 

  • Salah-Eldin AE, Inoue S, Tsukamoto S, Aoi H, Tsuda M (2003) An association of Bcl-2 phosphorylation and Bax localization with their functions after hyperthermia and paclitaxel treatment. Int J Cancer 103:53–60

    Article  CAS  PubMed  Google Scholar 

  • Scarlett JL, Sheard PW, Hughes G, Ledgerwood EC, Ku HH, Murphy MP (2000) Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett 475:267–272

    Article  CAS  PubMed  Google Scholar 

  • Schiff PB, Horwitz SB (1981) Taxol assembles tubulin in the absence of exogenous guanosine 5′-triphosphate or microtubule-associated proteins. Biochemistry 20:3247–3252

    Article  CAS  PubMed  Google Scholar 

  • Sergeev IN (2004) Genistein induces Ca2+ -mediated, calpain/caspase-12-dependent apoptosis in breast cancer cells. Biochem Biophys Res Commun 321:462–467

    Article  CAS  PubMed  Google Scholar 

  • Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G (1997) Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother Pharmacol 40 suppl:S13–S19

    Google Scholar 

  • Silbergeld DL, Chicoine MR, Madsen CL (1995) In vitro assessment of Taxol for human glioblastoma: chemosensitivity and cellular locomotion. Anticancer Drugs 6:270–276

    Article  CAS  PubMed  Google Scholar 

  • Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 61:6674–6678

    CAS  PubMed  Google Scholar 

  • Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS, Severin SE, Uhl R, Kock M, Geiger KD, Gelperina SE (2004) Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer 109:759–767

    Article  CAS  PubMed  Google Scholar 

  • Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011–1018

    Article  CAS  PubMed  Google Scholar 

  • Sun J, Huang H, Zhu Y, Lan J, Li J, Lai X, Yu J (2005) The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells. Int J Hematol 82:215–223

    Article  CAS  PubMed  Google Scholar 

  • Suri SS, Fenniri H, Singh B (2007) Nanotechnology-based drug delivery systems. J Occup Med Toxicol 2:16

    Article  PubMed  CAS  Google Scholar 

  • Tarr BD, Yalkowsky SH (1987) A new parenteral vehicle for the administration of some poorly water soluble anti-cancer drugs. J Parenter Sci Technol 41:31–33

    CAS  PubMed  Google Scholar 

  • Tascos NA, Parr J, Gonatas NK (1982) Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system. Hum Pathol 13:454–458

    Article  CAS  PubMed  Google Scholar 

  • Terzis AJ, Thorsen F, Heese O, Visted T, Bjerkvig R, Dahl O, Arnold H, Gundersen G (1997) Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. Br J Cancer 75:1744–1752

    Article  CAS  PubMed  Google Scholar 

  • Thalasila A, Poplin E, Shih J, Dvorzhinski D, Capanna T, Doyle-Lindrud S, Beers S, Goodin S, Rubin E, DiPaola RS (2003) A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies. Cancer Chemother Pharmacol 52:119–124

    Article  CAS  PubMed  Google Scholar 

  • Tseng SH, Bobola MS, Berger MS, Silber JR (1999) Characterization of paclitaxel (Taxol) sensitivity in human glioma- and medulloblastoma-derived cell lines. Neuro Oncol 1:101–108

    CAS  PubMed  Google Scholar 

  • Tsujimoto Y (2003) Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195:158–167

    Article  CAS  PubMed  Google Scholar 

  • Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967–1972

    CAS  PubMed  Google Scholar 

  • Tudor G, Aguilera A, Halverson DO, Laing ND, Sausville EA (2000) Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels. Cell Death Differ 7:574–586

    Article  CAS  PubMed  Google Scholar 

  • Vaishampayan U, Flaherty L, Du W, Hussain M (2001) Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma. Cancer 92:519–523

    Article  CAS  PubMed  Google Scholar 

  • van Asperen J, Mayer U, van Tellingen O, Beijnen JH (1997) The functional role of P-glycoprotein in the blood-brain barrier. J Pharm Sci 86:881–884

    Article  PubMed  Google Scholar 

  • Veal GJ, Errington J, Redfern CP, Pearson AD, Boddy AV (2002) Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells. Biochem Pharmacol 63:207–215

    Article  CAS  PubMed  Google Scholar 

  • von Haefen C, Wieder T, Essmann F, Schulze-Osthoff K, Dörken B, Daniel PT (2003) Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop. Oncogene 22:2236–2247

    Article  CAS  Google Scholar 

  • Wang CY, Mayo MW, Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784–787

    Article  CAS  PubMed  Google Scholar 

  • Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr (1998) NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680–1683

    Article  CAS  PubMed  Google Scholar 

  • Wang LG, Liu XM, Kreis W, Budman DR (1999) The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 44:355–361

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Martindale JL, Holbrook NJ (2000) Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275:39435–39443

    Article  CAS  PubMed  Google Scholar 

  • Wang PP, Frazier J, Brem H (2002) Local drug delivery to the brain. Adv Drug Deliv Rev 54:987–1013

    Article  CAS  PubMed  Google Scholar 

  • Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93:2325–2327

    Article  CAS  PubMed  Google Scholar 

  • Warner HR (1997) Aging and regulation of apoptosis. Curr Top Cell Regul 35:107–121

    Article  CAS  PubMed  Google Scholar 

  • Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, Baker JR Jr, Van Echo DA, Von Hoff DD, Leyland-Jones B (1990) Hypersensitivity reactions from taxol. J Clin Oncol 8:1263–1268

    CAS  PubMed  Google Scholar 

  • Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jääskeläinen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5:79–88

    CAS  PubMed  Google Scholar 

  • White CM, Martin BK, Lee LF, Haskill JS, Ting JP (1998) Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells. Cancer Immunol Immunother 46:104–112

    Article  CAS  PubMed  Google Scholar 

  • Witcher M, Ross DT, Rousseau C, Deluca L, Miller WH Jr (2003) Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells. Blood 102:237–245

    Article  CAS  PubMed  Google Scholar 

  • Xia L, Wurmbach E, Waxman S, Jing Y (2006) Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis. Leukemia 20:1009–1016

    Article  CAS  PubMed  Google Scholar 

  • Yacoub A, Han SI, Caron R, Gilfor D, Mooberry S, Grant S, Dent P (2003) Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitro. Cancer Biol Ther 2:670–676

    CAS  PubMed  Google Scholar 

  • Yamini B, Yu X, Gillespie GY, Kufe DW, Weichselbaum RR (2004) Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma. Cancer Res 64:6381–6384

    Article  CAS  PubMed  Google Scholar 

  • Yan Q, Matheson C, Sun J, Radeke MJ, Feinstein SC, Miller JA (1994) Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression. Exp Neurol 127:23–36

    Article  CAS  PubMed  Google Scholar 

  • Yoo HS, Lee KH, Oh JE, Park TG (2000) In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Release 68:419–431

    Article  CAS  PubMed  Google Scholar 

  • Yu Z, Xing Y (2006) ATRA-induced apoptosis of mouse embryonic palate mesenchymal cells involves activation of MAPK pathway. Toxicol Appl Pharmacol 215:57–63

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by the R01 grants (CA-91460 and NS-57811) from the National Institutes of Health (Bethesda, MD) to S.K.R.

Author information

Authors and Affiliations

  1. Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Building 2, Room C11, 6439 Garners Ferry Road, Columbia, SC, 29209, USA

    Swapan K. Ray

Authors
  1. Surajit Karmakar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naren L. Banik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Swapan K. Ray
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Swapan K. Ray .

Editor information

Editors and Affiliations

  1. Dept. Neurosciences, Medical University of South Carolina, Jonathan Lucas St. 96 , Charleston, 29425, U.S.A.

    Swapan K. Ray

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag New York

About this chapter

Cite this chapter

Karmakar, S., Banik, N.L., Ray, S.K. (2010). Current Endeavors for Enhancing Efficacy of Paclitaxel for Treatment of Glioblastoma. In: Ray, S. (eds) Glioblastoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0410-2_15

Download citation

Publish with us

Policies and ethics

Search

Navigation